Clinical and neuropsychological characteristics of Huntington's disease: A review

被引:10
作者
Arango-Lasprilla, JC
Iglesias-Dorado, J
Lopera, F
机构
[1] Univ Antioquia, Grp Neurociencias, Medellin, Colombia
[2] Univ Autonoma Madrid, Dept Psicol Biol & Salud, Madrid, Spain
关键词
basal ganglia; caudate nucleus and putamen dementia; Huntington's disease; neuropsychological evaluation;
D O I
10.33588/rn.3708.2003010
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Huntington's disease is a dominant autosomic neurodegenerative disorder. This article's objective is to provide an up-to-date description of the clinical and neuropsychological manifestations over the course of the disease. Method. According to clinical studies, the main characteristics of Huntington's disease include motor deficits, psychiatric problems and cognitive deficits. Many investigations have shown that a fronto-subcortical circuit dysfunction is responsible for these deficits. As the disease progresses, patients tend to have more cognitive difficulties which include attention/concentration problems, slowed cognitive processing, memory and language deficits, visuo-spatial problems and executive functioning difficulties. Conclusion. Studies with asymptomatic carriers of Huntington's disease have shown that cognitive deterioration may begin long before a clinical diagnosis of the disease is possible.
引用
收藏
页码:758 / 765
页数:8
相关论文
共 130 条
[1]  
ALBERT M S, 1981, Journal of Clinical Neuropsychology, V3, P1, DOI 10.1080/01688638108403109
[2]   SUBCORTICAL DEMENTIA OF PROGRESSIVE SUPRANUCLEAR PALSY [J].
ALBERT, ML ;
FELDMAN, RG ;
WILLIS, AL .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1974, 37 (02) :121-130
[3]  
[Anonymous], 2004, Neuropsychological Assessment
[4]   A neuropsychological study of Huntington's disease in families in Antioquia, Colombia [J].
Arango-Lasprilla, JC ;
Iglesias-Dorado, J ;
Moreno, S ;
Lopera, F .
REVISTA DE NEUROLOGIA, 2003, 37 (01) :7-13
[5]   Frontal lobe volume in patients with Huntington's disease [J].
Aylward, EH ;
Anderson, NB ;
Bylsma, FW ;
Wagster, MV ;
Barta, PE ;
Sherr, M ;
Feeney, J ;
Davis, A ;
Rosenblatt, A ;
Pearlson, GD ;
Ross, CA .
NEUROLOGY, 1998, 50 (01) :252-258
[6]   Retest effects and cognitive decline in longitudinal follow-up of patients with early HD [J].
Bachoud-Lévi, AC ;
Maison, P ;
Bartolomeo, P ;
Boissé, MF ;
Dalla Barba, G ;
Ergis, AM ;
Baudic, S ;
Degos, JD ;
Cesaro, P ;
Peschanski, M .
NEUROLOGY, 2001, 56 (08) :1052-1058
[7]   Cognitive deficits in Huntington's disease are predicted by dopaminergic PET markers and brain volumes [J].
Bäckman, L ;
Robins-Wahlin, TB ;
Lundin, A ;
Ginovart, N ;
Farde, L .
BRAIN, 1997, 120 :2207-2217
[8]   CLINICAL-PATHOLOGIC CORRELATION IN HUNTINGTONS-DISEASE - A NEUROPSYCHOLOGICAL AND COMPUTED-TOMOGRAPHY STUDY [J].
BAMFORD, KA ;
CAINE, ED ;
KIDO, DK ;
PLASSCHE, WM ;
SHOULSON, I .
NEUROLOGY, 1989, 39 (06) :796-801
[9]  
BARBEAU A, 1970, LANCET N AM ED, V31, P937
[10]  
BARMA H, 1998, J NEUROL NEUROSUR PS, V64, P172